Balaxi [BALAXI] vs Zota Health Care [ZOTA] Detailed Stock Comparison
Balaxi
NSE
Loading...
Zota Health Care
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Balaxi wins in 10 metrics, Zota Health Care wins in 6 metrics, with 0 ties. Balaxi appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Balaxi | Zota Health Care | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.62 | N/A | N/A |
| Price-to-Book Ratio | 1.04 | 20.03 | Balaxi |
| Debt-to-Equity Ratio | 9.64 | 65.72 | Balaxi |
| EV/EBITDA | 12.49 | -91.53 | Zota Health Care |
| Profit Margin (TTM) | -0.99% | -20.55% | Balaxi |
| Operating Margin (TTM) | 21.39% | -24.15% | Balaxi |
| EBITDA Margin (TTM) | 21.39% | N/A | N/A |
| Return on Equity | -1.24% | -24.83% | Balaxi |
| Return on Assets (TTM) | 11.20% | -12.84% | Balaxi |
| Free Cash Flow (TTM) | $-567.67M | $-959.42M | Balaxi |
| Dividend Yield | N/A | 0.11% | N/A |
| 1-Year Return | -60.10% | 85.82% | Zota Health Care |
| Price-to-Sales Ratio (TTM) | 0.92 | 12.67 | Balaxi |
| Enterprise Value | $5.84B | $34.38B | Zota Health Care |
| EV/Revenue Ratio | 2.42 | 14.01 | Balaxi |
| Gross Profit Margin (TTM) | 48.13% | 50.78% | Zota Health Care |
| Revenue per Share (TTM) | $47 | $92 | Zota Health Care |
| Earnings per Share (Diluted) | $4.54 | $-20.73 | Balaxi |
| Beta (Stock Volatility) | 0.59 | 0.45 | Zota Health Care |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Balaxi vs Zota Health Care Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Balaxi | -4.67% | -7.79% | -12.76% | -17.12% | -35.78% | -39.35% |
| Zota Health Care | -0.78% | -0.78% | -2.36% | 45.12% | 25.14% | 50.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Balaxi | -60.10% | -50.18% | -43.77% | 1,355.67% | 1,355.67% | 1,355.67% |
| Zota Health Care | 85.82% | 335.52% | 755.41% | 1,223.25% | 1,223.25% | 1,223.25% |
Performance & Financial Health Analysis: Balaxi vs Zota Health Care
| Metric | BALAXI | ZOTA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.22B | ₹31.09B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 270,498 | 74,456 |
| 90 Day Avg. Volume | 367,665 | 156,797 |
| Last Close | ₹43.67 | ₹1,202.70 |
| 52 Week Range | ₹42.56 - ₹127.45 | ₹535.00 - ₹1,305.00 |
| % from 52W High | -65.74% | -7.84% |
| All-Time High | ₹216.04 (Oct 12, 2020) | ₹1,305.00 (Jul 10, 2025) |
| % from All-Time High | -79.79% | -7.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.26% | 0.54% |
| Quarterly Earnings Growth | 0.35% | 0.96% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | -0.21% |
| Operating Margin (TTM) | 0.21% | -0.24% |
| Return on Equity (TTM) | -0.01% | -0.25% |
| Debt to Equity (MRQ) | 9.64 | 65.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹41.98 | ₹60.04 |
| Cash per Share (MRQ) | ₹11.86 | ₹0.84 |
| Operating Cash Flow (TTM) | ₹48.66M | ₹-1,007,999,000 |
| Levered Free Cash Flow (TTM) | ₹395.72M | ₹-563,984,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.11% |
| Last 12-Month Dividend | ₹0.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Balaxi vs Zota Health Care
| Metric | BALAXI | ZOTA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.62 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 0.92 | 12.67 |
| Price to Book (MRQ) | 1.04 | 20.03 |
| Market Capitalization | ||
| Market Capitalization | ₹2.22B | ₹31.09B |
| Enterprise Value | ₹5.84B | ₹34.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.42 | 14.01 |
| Enterprise to EBITDA | 12.49 | -91.53 |
| Risk & Other Metrics | ||
| Beta | 0.59 | 0.45 |
| Book Value per Share (MRQ) | ₹41.98 | ₹60.04 |
Financial Statements Comparison: Balaxi vs Zota Health Care
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BALAXI | ZOTA |
|---|---|---|
| Revenue/Sales | ₹762.66M | ₹972.75M |
| Cost of Goods Sold | ₹395.57M | ₹478.75M |
| Gross Profit | ₹367.09M | ₹494.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹120.92M | ₹-118.49M |
| EBITDA | ₹108.59M | ₹34.68M |
| Pre-Tax Income | ₹96.63M | ₹-143.05M |
| Income Tax | ₹10.25M | ₹-14.16M |
| Net Income (Profit) | ₹86.38M | ₹-128.89M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BALAXI | ZOTA |
|---|---|---|
| Cash & Equivalents | ₹394.00M | ₹21.32M |
| Total Current Assets | ₹2.43B | ₹1.84B |
| Total Current Liabilities | ₹545.32M | ₹1.01B |
| Long-Term Debt | ₹230.46M | ₹1.08B |
| Total Shareholders Equity | ₹2.32B | ₹2.27B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹142.40M | ₹1.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BALAXI | ZOTA |
|---|---|---|
| Operating Cash Flow | N/A | ₹-8.57M |
| Capital Expenditures | N/A | ₹-982,011 |
| Free Cash Flow | N/A | ₹41.94M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BALAXI | ZOTA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 270,498 | 74,456 |
| Average Daily Volume (90 Day) | 367,665 | 156,797 |
| Shares Outstanding | 50.91M | 25.85M |
| Float Shares | 51.20M | 8.71M |
| % Held by Insiders | N/A | 0.00% |
| % Held by Institutions | N/A | 0.00% |
Dividend Analysis & Yield Comparison: Balaxi vs Zota Health Care
| Metric | BALAXI | ZOTA |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.11% |
| 3-Year Avg Annual Dividend | ₹0.01 | ₹1.17 |
| 3-Year Avg Dividend Yield | 0.03% | 0.30% |
| 3-Year Total Dividends | ₹0.02 | ₹3.50 |
| Ex-Dividend Date | Jul 01, 2022 | Sep 20, 2024 |